Results 181 to 190 of about 788,644 (353)

Vasculitis-Like Hemorrhagic Herpes Zoster and HIV Infections: An Intricate Association. [PDF]

Cureus, 2023
Cozma EC, Banciu LM, Soare C, Găman MA, Voiculescu VM.   +4 more
europepmc   +1 more source

Mapping opioid exposure through prescription data and postmortem analysis of opioid drugs in multiple tissues

British Journal of Clinical Pharmacology, EarlyView.
Background and Purpose Although opioids are central to end of life (EoL) care, tissue‐level opioid exposure remains poorly understood. The objective of this study was to characterize the relationship between prescription‐derived morphine equivalent daily dose (MEDD) and measured morphine concentrations across multiple organs.
Niamh Higgins, Alan Wells, Nimish Patel, Nicole Muttera, Mattia Trunfio, Alessandra Manca, Amedeo De Nicolò, Micol Ferrara, Stefano Bonora, Jessica Cusato, Alice Palermiti, Antonio D'Avolio, Marissa Borochoff, Patricia K. Riggs, Elizabeth Hastie, Rabia S. Atayee, Stephanie Solso, Cheryl Dullano, Vanessa Gomez‐Moreno, Tara Tenenbaum, Robert Deiss, Davey M. Smith, Antoine Chaillon, Sara Gianella   +23 more
wiley   +1 more source

Rising HIV infections and shifting transmission patterns in Bangladesh: Emerging risks among key populations. [PDF]

Prev Med Rep
Hawk A, Akter M, Adebayo UO, Jamil S.
europepmc   +1 more source

Unsuspected HIV infection in first year of life

, 1995
David Nunns
openalex   +2 more sources

Active surveillance of drug safety in healthcare data: Sequential monitoring of bacterial and serious urinary tract infection risk in sodium‐glucose cotransporter 2 inhibitor users

British Journal of Clinical Pharmacology, EarlyView.
Abstract Introduction Active surveillance of adverse events using healthcare data is emerging as complementary to the monitoring of spontaneous reports and stand‐alone pharmacoepidemiologic studies. The risk of urinary tract infections (UTIs) was listed as a special warning for sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) when marketed in Europe
Haoxin Le, Dilsad Simay Peker, Lukas Frederic Westphal, Nikolai Brun, Christine Erikstrup Hallgreen, Morten Andersen   +5 more
wiley   +1 more source

Geospatial and phylogenetic clustering of acute and recent HIV infections in Lilongwe, Malawi. [PDF]

PLOS Glob Public Health
Bell GJ, Powers KA, Ratmann O, Dennis AM, Mmodzi P, Matoga M, Jere E, Chen JS, Maierhofer CN, Rutstein SE, Lancaster KE, Chagomerana MB, Bonongwe N, Mathiya E, Ndalama B, Bonsall D, Weir SS, Hosseinipour MC, Emch M, Cohen MS, Hoffman IF, Miller WC.   +21 more
europepmc   +1 more source

Effects of doxycycline post-exposure prophylaxis on bacterial sexually transmitted infections and antiretroviral therapy adherence among adolescents and young adults living with HIV

Timothy J. Howze, Sean M. Graves, Susan D. Carr, Gina Sabbatini, Tiffany M. Nason, Nehali Patel   +5 more
openalex   +1 more source

PREVALENCE OF FUNGAL IN OPPORTUNISTIC INFECTION HIV TYPE-1 IN SUBURBAN, KADAPA

, 2017
G. Obulesu, Hanumanthapp Ar, Prabakar Reddy E   +2 more
openalex   +2 more sources

Diagnosing HIV infection [PDF]

Clinical Medicine, 2003
openaire   +2 more sources

PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4+ lymphocytes

British Journal of Clinical Pharmacology, EarlyView.
Background Female sex hormones used in feminizing hormone therapy (FHT) may influence activation and persistence of HIV pre‐exposure prophylaxis (PrEP) medications. The clinical relevance of this interaction remains unclear, particularly for transgender and cisgender women (TGW and CGW).
Elizabeth Hastie, Megha Srivasta, Edward R. Cachay, Leah Burke, Sara Gianella, Stephen Rawlings, Frank Z. Stanczyk, Craig Sykes, Angela D. M. Kashuba, Jill Blumenthal, Mackenzie L. Cottrell   +10 more
wiley   +1 more source